Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesPhase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers
Journal of Clinical Oncology, 09/04/09
Antonarakis ES et al. – Treatment with 4 to 6 weeks of celecoxib had no effect on intermediate biomarkers of prostate carcinogenesis, despite the achievement of measurable tissue levels. The authors caution against using celecoxib 400 mg twice daily as a preventive agent for prostate cancer in additional studies.
Related Articles
Celecoxib in arthritis: relative risk management profile and implications for patients
Therapeutics and Clinical Risk Management, 11/10/09
Relevance Score: 89%
Cyclin-mediated G1 Arrest by Celecoxib Differs in Low-versus High-grade Bladder Cancer
Anticancer Research, 11/10/09
Relevance Score: 85%
Clinical trial: the impact of cyclooxygenase inhibitors on gastrointestinal recovery after major surgery - a randomized double blind controlled trial of celecoxib or diclofenac vs. placebo
Alimentary Pharmacology and Therapeutics, 10/21/09
Relevance Score: 85%
Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis
Journal of Hypertension, 11/20/09
Relevance Score: 80%
A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract
Journal of Rheumatology, 11/18/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical aspects and epidemiology of uncomplicated cystitis in women-German results of the ARESC Study
Der Urologe, 12/07/09
Efficacy and Tolerability of Fesoterodine in Men With Overactive Bladder: A Pooled Analysis of 2 Phase III Studies
Urology, 12/07/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/07/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Excision of carcinoma in situ of the glans penis with reconstructive plastic surgery
Der Urologe, 12/08/09
Total Cystectomy Versus Bladder Preservation Therapy for Locally Invasive Bladder Cancer: Effect of Combined Therapy Using Balloon-Occluded Arterial Infusion of Anticancer Agent and Hemodialysis With Concurrent Radiation
American Journal of Clinical Oncology, 12/07/09
Udp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer
International Journal of Cancer, 12/07/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Holmium Laser Applications of the Prostate
Urologic Clinics of North America, 12/07/09
KTP/LBO Laser Vaporization of the Prostate
Urologic Clinics of North America, 12/07/09
Electroresection and Open Surgery
Urologic Clinics of North America, 12/07/09
Article Search
Sponsor